OOIR: Observatory of International Research

Papers

(The TQCC of Pigment Cell & Melanoma Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Issue Information	96
	55
How a membrane transporter keeps melanocytes in the red	52
	48
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells	42
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes	41
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy	37
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma	33
Let’s talk about sex: A biological variable in immune response against melanoma	32
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies	31
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)	25
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing	25
Issue Information	23
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis	23
Issue Information	22
Issue Information	22
25th International Pigment Cell Conference, Bilbao, Spain IPCC 2023	18
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes	18
Progress in melanoma treatment: Patient's perspectives	17
Single‐cell profiling of MC1R‐inhibited melanocytes	16
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend	16
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6	16
Abstracts	15
Issue Information	14
	14

Corrigendum	14
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma	13
Issue Information	13
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling	13
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database	13
PASPCR 2024 Annual Meeting, New York, NY	13
Corrigendum	13
	12
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells	12
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population	11
Cover Image	11
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models	11
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma	10
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023	10
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes	10
	10
	9
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐1	9
Issue Information	8
Two novel CreER^T2 transgenic mouse lines to study melanocytic cells in vivo	7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages	7
Cover Image	7
The delicate relation between melanocytes and skin immunity: A game of hide and seek	7
Issue Information	7
Cover Image	7
Special issue: “Biology of skin pigmentation and pigmentary diseases”	6
The metabolism of melanin synthesis—From melanocytes to melanoma	6
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines	6
Issue Information	6
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment	6
Topical antibiotics limit depigmentation in a mouse model of vitiligo	6
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma	5
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/6	5
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 2015	5
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production	5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model	5
Three‐dimensional imaging for the analysis of human epidermal melanocytes	5
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation	5
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas	4
TFE3 promotes ferroptosis in melanoma	4
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants	4
ToF‐SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma	4
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation	4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era	4
Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population	4
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance	4
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines	4
Issue Information	4
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment	4
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity	4

Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism